immune hyperactivation in COVID-19 patients and/or acute respiratory distress syndrome research hub

efficacy and safety of the use of regulatory T cells in immune hyperactivation in patients with COVID-19 and/or acute respiratory distress syndrome

This study is looking at a new treatment involving special immune cells for people very sick with COVID-19 or a severe lung problem called ARDS. It aims to see if this treatment is safe and helps calm down an overactive immune system, which can make these illnesses worse.